Hepatitis B Core Antibody Blood Test: Normal Ranges, Causes & What Your Results Mean

What Is Hepatitis B Core Antibody?

Hepatitis B core antibody (anti-HBc) is a blood marker that indicates whether you have ever been exposed to the hepatitis B virus (HBV). Unlike other hepatitis B markers, anti-HBc is not produced in response to vaccination - it appears only after natural infection with the virus.

The hepatitis B virus contains a core protein (HBcAg) located within the viral particle. When your immune system encounters this protein during an HBV infection, it produces antibodies against it. These core antibodies come in two forms:

• Anti-HBc IgM: Appears early in infection and indicates acute or recently acquired hepatitis B. It is typically detectable within 1-2 weeks of symptoms and remains positive for approximately 6 months.
• Anti-HBc IgG: Develops during or shortly after an acute infection and persists for life. Its presence indicates that the person has been infected with HBV at some point, regardless of whether the infection resolved or became chronic.

The total anti-HBc test (which detects both IgM and IgG) is one of the most important markers in the hepatitis B screening pathway. A positive result always warrants further investigation with additional hepatitis B markers to determine the stage and significance of infection.

Hepatitis B is a significant global health concern. In the UK, Public Health England estimates that approximately 180,000 people are chronically infected, with many unaware of their status. The virus is transmitted through blood, sexual contact, and from mother to child during childbirth.

Why Is Hepatitis B Core Antibody Tested?

Anti-HBc testing serves several essential clinical purposes:

• Comprehensive hepatitis B screening: Anti-HBc is part of the standard hepatitis B panel (alongside HBsAg and anti-HBs) recommended by NICE and the British Association for the Study of the Liver (BASL) for initial screening.
• Blood donation screening: NHS Blood and Transplant tests all donations for anti-HBc. A positive result typically disqualifies the donation to prevent potential transmission.
• Pre-transplant assessment: Before organ or bone marrow transplantation, anti-HBc testing helps assess the risk of HBV reactivation under immunosuppressive therapy.
• Before immunosuppressive therapy: NICE recommends hepatitis B screening (including anti-HBc) before starting biological therapies, chemotherapy, or other immunosuppressive treatments, as these can cause reactivation of latent HBV.
• Antenatal screening: Pregnant women are screened for hepatitis B to prevent mother-to-child transmission. Whilst HBsAg is the primary screening test, anti-HBc helps complete the clinical picture.
• Differentiating infection from vaccination: Someone who has been vaccinated will have anti-HBs (surface antibody) but will be anti-HBc negative. Someone who has recovered from natural infection will typically be positive for both anti-HBs and anti-HBc.
• Investigating abnormal liver function: If liver enzymes (ALT, AST) are elevated without a clear cause, hepatitis B screening including anti-HBc helps rule out or confirm viral hepatitis as the underlying cause.

Normal Ranges

Anti-HBc results are reported as reactive (positive) or non-reactive (negative). Some laboratories also report equivocal results that require repeat testing.

Result	Interpretation
Non-reactive (Negative)	No evidence of current or past hepatitis B infection
Reactive (Positive)	Exposure to hepatitis B virus - current or past infection. Further testing needed to determine clinical significance
Equivocal	Indeterminate result - repeat testing recommended in 2-4 weeks

A positive anti-HBc result must always be interpreted alongside other hepatitis B markers. The following table shows common interpretation patterns:

HBsAg	Anti-HBs	Anti-HBc	Interpretation
Negative	Negative	Negative	No infection; not immune; vaccination may be recommended
Negative	Positive	Negative	Immune due to vaccination
Negative	Positive	Positive	Immune due to past natural infection (resolved)
Positive	Negative	Positive	Current infection (acute or chronic - IgM anti-HBc distinguishes)
Negative	Negative	Positive	"Isolated anti-HBc" - several possible explanations (see below)

What Do Positive Hepatitis B Core Antibody Results Mean?

A positive (reactive) anti-HBc result indicates that you have been infected with the hepatitis B virus at some point. The clinical significance depends on which other markers are also positive:

• Resolved infection: The most common scenario. If anti-HBc is positive alongside positive anti-HBs and negative HBsAg, this indicates that you were infected in the past but your immune system successfully cleared the virus. You are now naturally immune.
• Chronic hepatitis B: If anti-HBc is positive alongside positive HBsAg and negative anti-HBs, this typically indicates an ongoing chronic infection. Approximately 5% of adults infected with HBV develop chronic hepatitis B.
• Acute infection: If anti-HBc IgM is positive, this suggests a recent or current acute infection. Acute hepatitis B in adults resolves spontaneously in approximately 95% of cases.
• Isolated anti-HBc: A positive anti-HBc result with both negative HBsAg and negative anti-HBs is referred to as "isolated anti-HBc." This pattern has several possible explanations, including: a resolved infection where anti-HBs levels have waned below detection; a low-level chronic infection ("occult hepatitis B"); a false positive result; or the "window period" between acute infection and immune clearance.
• Reactivation risk: Even in individuals with resolved infection, HBV DNA can persist in the liver at low levels. If the immune system is significantly suppressed (by chemotherapy, organ transplant anti-rejection drugs, or biological therapies such as rituximab), HBV can reactivate - making prior anti-HBc positivity clinically very important.
• Occult hepatitis B: In rare cases, anti-HBc positivity with negative HBsAg may indicate "occult" hepatitis B, where low levels of HBV DNA are present in the liver despite undetectable surface antigen. HBV DNA testing can clarify this.

What Do Negative Hepatitis B Core Antibody Results Mean?

A negative (non-reactive) anti-HBc result generally indicates:

• No previous HBV infection: You have never been exposed to the hepatitis B virus through natural infection. This is the most common interpretation.
• Vaccination immunity only: If you have been vaccinated against hepatitis B, you will typically be anti-HBs positive but anti-HBc negative, confirming that your immunity comes from vaccination rather than natural infection.
• Very early infection: In the earliest stages of acute hepatitis B (the incubation period), anti-HBc may not yet be detectable. If clinical suspicion is high, repeat testing in 2-4 weeks is advised.
• Immunosuppression: In severely immunocompromised individuals, anti-HBc may fail to develop or may become undetectable despite true infection. This is uncommon but recognised.
• Waning antibodies: In very rare cases, anti-HBc IgG levels may decline below the detection threshold many decades after infection, though this is unusual as anti-HBc IgG typically persists for life.

How to Improve Your Hepatitis B Status

Unlike many biomarkers, hepatitis B core antibody levels cannot be "improved" through lifestyle changes - a positive result reflects a historical immunological event. However, there are important steps you can take depending on your overall hepatitis B status:

If You Have Resolved Infection (Anti-HBc Positive, Anti-HBs Positive)

• No treatment needed: You are naturally immune. However, be aware of the small risk of reactivation if you ever require immunosuppressive therapy. Inform any healthcare provider about your hepatitis B history before starting such treatments.
• Monitor liver health: Regular liver function tests can provide reassurance and detect any unlikely changes.
• Limit alcohol: Protect your liver by keeping alcohol consumption within the NHS guidelines of 14 units per week.

If You Have Chronic Hepatitis B

• Specialist referral: NICE recommends that all patients with chronic hepatitis B are managed by a hepatologist or infectious disease specialist. Regular monitoring of HBV DNA levels, liver function, and liver fibrosis assessment (FibroScan) is essential.
• Antiviral therapy: Medications such as tenofovir or entecavir can suppress viral replication, reduce liver damage, and lower the risk of cirrhosis and hepatocellular carcinoma.
• Liver-protective lifestyle: Avoid alcohol, maintain a healthy weight, eat a balanced diet rich in fruits, vegetables, and lean protein, and avoid hepatotoxic substances.
• Vaccination of close contacts: Household members and sexual partners should be vaccinated against hepatitis B if they are not already immune.
• Regular surveillance: Patients with chronic hepatitis B require 6-monthly ultrasound surveillance for hepatocellular carcinoma, as recommended by NICE and BASL guidelines.

If You Are Not Immune (All Markers Negative)

• Get vaccinated: The hepatitis B vaccine is safe, effective, and available on the NHS for at-risk groups. Since September 2017, it has been part of the routine childhood immunisation schedule in the UK. Adults at risk (healthcare workers, people who inject drugs, sexual partners of infected individuals, travellers to endemic areas) should also be vaccinated.

When Should You Get Tested?

Consider hepatitis B screening, including anti-HBc testing, if:

• You were born in a country with intermediate or high hepatitis B prevalence (sub-Saharan Africa, East Asia, Pacific Islands, Eastern Europe)
• You have a sexual partner who is hepatitis B positive
• You are a man who has sex with men
• You have ever injected drugs
• You are a healthcare worker or have occupational exposure to blood
• You are starting immunosuppressive therapy, chemotherapy, or biological agents
• You have unexplained liver enzyme elevation
• You are pregnant (routine antenatal screening includes HBsAg)
• You are a household contact of someone with hepatitis B
• You are donating blood, organs, or tissue

Public Health England estimates that a significant proportion of people with chronic hepatitis B in the UK remain undiagnosed. Early detection enables monitoring, treatment when indicated, and prevention of onward transmission.

Which Lola Health Tests Include Hepatitis B Core Antibody?

Lola Health offers blood testing that helps you understand your liver health and infection status:

• Peak Insights - Our most detailed health panel, including liver function markers and a broad range of biomarkers for a thorough health assessment.
• Vital Check — A detailed wellness assessment that includes key liver and immune markers to monitor your overall health.
• Core Health — An essential health check covering foundational biomarkers including liver function to help identify potential concerns.

All Lola Health tests use venous blood draws performed by qualified phlebotomists for medical-grade accuracy. Results are reviewed by GP-certified professionals and delivered with personalised health recommendations.